Publications:

---

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.

Nature Communications

Frontzek, Fabian F; Staiger, Annette M AM; Zapukhlyak, Myroslav M; Xu, Wendan W; Bonzheim, Irina I; Borgmann, Vanessa V; Sander, Philip P; Baptista, Maria Joao MJ; Heming, Jan-Niklas JN; Berning, Philipp P; Wullenkord, Ramona R; Erdmann, Tabea T; Lutz, Mathias M; Veratti, Pia P; Ehrenfeld, Sophia S; Wienand, Kirsty K; Horn, Heike H; Goodlad, John R JR; Wilson, Matthew R MR; Anagnostopoulos, Ioannis I; Lamping, Mario M; Gonzalez-Barca, Eva E; Climent, Fina F; Salar, Antonio A; Castellvi, Josep J; Abrisqueta, Pau P; Menarguez, Javier J; Aldamiz, Teresa T; Richter, Julia J; Klapper, Wolfram W; Tzankov, Alexandar A; Dirnhofer, Stefan S; Rosenwald, Andreas A; Mate, José Luis JL; Tapia, Gustavo G; Lenz, Peter P; Miething, Cornelius C; Hartmann, Wolfgang W; Chapuy, Björn B; Fend, Falko F; Ott, German G; Navarro, José-Tomas JT; Grau, Michael M; Lenz, Georg G

Publication Date: 2021-08-31

Variant appearance in text: TET2: 3866G>C; C1289S

PubMed Link: 34465776

Variant Present in the following documents:

• 41467_2021_25405_MOESM7_ESM.xlsx, sheet 2

View BVdb publication page

---

CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial.

Genome Medicine

Cai, Ming-Ci MC; Cheng, Shu S; Wang, Xin X; Hu, Jian-Da JD; Song, Yong-Ping YP; Huang, Yao-Hui YH; Yan, Zi-Xun ZX; Jiang, Yu-Jie YJ; Fang, Xiao-Sheng XS; Zheng, Xiao-Yun XY; Dong, Li-Hua LH; Ji, Meng-Meng MM; Wang, Li L; Xu, Peng-Peng PP; Zhao, Wei-Li WL

Publication Date: 2020-04-30

Variant appearance in text: TET2: C1289S

PubMed Link: 32349779

Variant Present in the following documents:

• 13073_2020_739_MOESM1_ESM.pdf

View BVdb publication page

---

Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.

Nature Communications

Nagata, Yasunobu Y; Makishima, Hideki H; Kerr, Cassandra M CM; Przychodzen, Bartlomiej P BP; Aly, Mai M; Goyal, Abhinav A; Awada, Hassan H; Asad, Mohammad Fahad MF; Kuzmanovic, Teodora T; Suzuki, Hiromichi H; Yoshizato, Tetsuichi T; Yoshida, Kenichi K; Chiba, Kenichi K; Tanaka, Hiroko H; Shiraishi, Yuichi Y; Miyano, Satoru S; Mukherjee, Sudipto S; LaFramboise, Thomas T; Nazha, Aziz A; Sekeres, Mikkael A MA; Radivoyevitch, Tomas T; Haferlach, Torsten T; Ogawa, Seishi S; Maciejewski, Jaroslaw P JP

Publication Date: 2019-11-26

Variant appearance in text: TET2: C1289S

PubMed Link: 31772163

Variant Present in the following documents:

• 41467_2019_13001_MOESM4_ESM.xlsx, sheet 1

View BVdb publication page

---

TET2 missense variants in human neoplasia. A proposal of structural and functional classification.

Molecular Genetics & Genomic Medicine

Bussaglia, Elena E; Antón, Rosa R; Nomdedéu, Josep F JF; Fuentes-Prior, Pablo P

Publication Date: 2019-07

Variant appearance in text: TET2: Cys1289Ser

PubMed Link: 31187595

Variant Present in the following documents:

• Main text
• MGG3-7-e00772.pdf

View BVdb publication page

---

The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.

Bmc Cancer

Wang, Ruiqi R; Gao, Xiaoning X; Yu, Li L

Publication Date: 2019-04-25

Variant appearance in text: TET2: C1289S

PubMed Link: 31023266

Variant Present in the following documents:

• 12885_2019_5602_MOESM2_ESM.xls, sheet 1

View BVdb publication page

---

A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens.

Blood Cancer Journal

Baccelli, I I; Krosl, J J; Boucher, G G; Boivin, I I; Lavallée, V-P VP; Hébert, J J; Lemieux, S S; Marinier, A A; Sauvageau, G G

Publication Date: 2017-02-17

Variant appearance in text: TET2: C1289S

PubMed Link: 28211886

Variant Present in the following documents:

• bcj201710x1.pdf

View BVdb publication page

---